Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. China
  4. Shanghai Stock Exchange
  5. Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
  6. News
  7. Summary
    600196   CNE000000X38

SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD.

(600196)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Fosun Pharma Forms Two Funds to Invest in New Drug-Related Projects

11/25/2021 | 04:10am EST


ę MT Newswires 2021
All news about SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD.
01/11Fosun Pharma and Insilico Medicine Announce a Strategic, AI-driven Drug Discovery and D..
AQ
01/11Fosun Pharma and Insilico Medicine Announces A Strategic, Ai-Driven Drug Discovery and ..
CI
01/07SHANGHAI FOSUN PHARMACEUTICAL : Entering into target fund lpa and possible continuing conn..
PU
01/06Chinese Regulators Accept Fosun Pharma Unit's Registration Application for Hemorrhage T..
MT
01/06SHANGHAI FOSUN PHARMACEUTICAL : Overseas regulatory announcement (h shares)
PU
01/04SHANGHAI FOSUN PHARMACEUTICAL : Appointment of vice chairman(h shares)
PU
01/04SHANGHAI FOSUN PHARMACEUTICAL : List of directors and their roles and function(h sh..
PU
01/04SHANGHAI FOSUN PHARMACEUTICAL : Monthly return of equity issuer on movements in securities..
PU
01/02Fosun Pharma Unit to Buy Stake in Pharmaceutical Firm for $141 Million
MT
2021Controlling Shareholder Ups Stake in Sisram Medical
MT
More news
Analyst Recommendations on SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD.
More recommendations
Financials
Sales 2021 36 412 M 5 732 M 5 732 M
Net income 2021 4 454 M 701 M 701 M
Net Debt 2021 12 120 M 1 908 M 1 908 M
P/E ratio 2021 28,2x
Yield 2021 0,99%
Capitalization 114 B 17 999 M 17 989 M
EV / Sales 2021 3,47x
EV / Sales 2022 2,94x
Nbr of Employees 32 258
Free-Float 58,6%
Chart SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD.
Duration : Period :
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD.
Short TermMid-TermLong Term
TrendsNeutralBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 11
Last Close Price 49,03 CNY
Average target price 65,43 CNY
Spread / Average Target 33,4%
EPS Revisions
Managers and Directors
Xiao Hui Guan Vice Chairman, Executive President & CEO
Yu Qing Chen Co-President
Ke Xin Wang Vice Chairman & Co-President
Dong Ming Li Co-President
Yi Fang Wu Chairman